REFERENCES
- Alea, J. A. & Aquilina, J. T. 1967. A comparison of oxyphencyclimine hydrochloride and probanthine bromide in patients with duodenal ulcer. Amer. J. dig. Dis. 12, 1122–1130.
- Berstad, A. 1970. A modified hemoglobin substrate method for the estimation of pepsin in gastric juice. Scand. J. Gastroent. 5, 343–348.
- Berstad, A. & Myren, J. 1969. The effect of oxyphencyclimine hydrochloride on the histamine- and pentapeptide-stimulated gastric secretion in man. Scand. J. Gastroent. 4, 305–309.
- Bonfils, S., Lewin, M., Vatier, J., Dubrasquet, M. & Bader, J. P. 1968. Correlation between acid and pepsin secretion in man (coefficient K 25). pp. 164–173 in Semb, L. S. & Myren, J. (eds.) The Physiology of Gastric Secretion, Universitetsforlaget, Oslo.
- Broomé, A. & Isacson, S.-O. 1967. Duration of anticholinergica. Opusc. med. (Stockh.) 12, 28–31.
- Douthwaite, A. H., Hills, T. H. & Hunt, J. N. 1961. Long-continued inhibition of gastric secretion by poldine methosulphate in patients with peptic ulcer. Brit. med. J. 1, 1575–1579.
- Hunt, J. N. & Wales, R. C. 1966. Progress in patients with peptic ulceration treated for more than five years with poldine, including a double-blind study. Brit. med. J. 2, 13–16.
- Kaye, M. D., Rhodes, J., Beck, P., Sweetnam, P. M., Davies, G. T. & Evans, K. T. 1970. A controlled trial of glycopyrronium and 1-hyoscyamine in the long-term treatment of duodenal ulcer. Gut 11, 559–566.
- Klotz, A. P. 1957. Therapeutic principles in management of peptic ulcer. Amer. J. dig. Dis. 4, 1048–1054.
- Mozsik, Gy., Javor, T., Dobi, S., Petrassy, K. & Szabo, A. 1967. Development of ‘pharmacological denervation phenomenon’ in patients treated with atropine. Europ. J. Pharmacol. 1, 391–395.
- Mozsik, Gy., Vizi, I., Javor, T. & Krausz, M. 1967. Correlation among gastric juice, acidity and electrolytes content during chronic atropine treatment on the patients. ‘Pharmacological denervation phenomenon’ on the gastric secretion, pp. 668–672 in Recent Advances in Gastroenterology, The Proceedings of the 3rd World Congress of Gastroenterology (Tokyo) Vol. I.
- Mozsik, Gy., Berstad, A., Myren, J. & Setekleiv, J. 1969. Absorption and urinary excretion of oxyphencyclimine HCl in patients before and after a prolonged oxyphencyclimine treatment. Med. exp. (Basel.) 19, 10–16.
- Norgaard, R. P., Polter, D. E., Wheeler, J. W., Jr. & Fordtran, J. S. 1970. Effect of long term anticholinergic therapy on gastric acid secretion with observations on the serial measurement of peak histalog response. Gastroenterology 58, 750–755.
- Piper, D. W. 1967. Antacids and anticholinergic drug therapy of peptic ulcer. Gastroenterology 52, 1009–1018.
- Piper, D. W., Elliott, F. M., Sietsma, A. S. & Pryor, A. W. 1960. The effect of a new anti-cholinergic agent, oxyphencyclimine hydrochloride, on gastric secretion. Med. J. Aust. 1, 236–240.
- Piper, D. W. & Fenton, B. H. 1965. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut 6, 506–508.
- Piper, D. W. & Stiel, M. C. 1962. A comparison of a series of newer anticholinergic agents with atropine as regards their effect on saliva flow and gastric secretion in man. Gut 3, 65–69.
- Sun, D. C. H. & Shay, H. 1956. Optimal effective dose of anticholinergic drug in peptic ulcer therapy. Arch. intern. Med. 97, 442–452.
- Venables, C. W. 1970. Relationship of pepsin secretion to the activity of duodenal ulceration (Abstract), in Riis, P., Antonisen, P. & Baden, H. (eds.) Advance Abstracts. 4th World Congress of Gastroenterology, Copenhagen 1970.
- Winkelstein, A. 1959. The clinical evaluation of oxyphencyclimine in patients with duodenal ulcer. Amer. J. Gastroent. 32, 66–70.